Related Experiment Video
Updated: Apr 21, 2026

06:41
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
9.6K
Does treatment with clomipramine reduce cat psychogenic alopecia?
Summary
Clomipramine did not effectively reduce overgrooming or alopecia in cats. Further research is needed to determine if clomipramine is effective alone or with other therapies for psychogenic alopecia.
Area of Science:
- Veterinary Medicine
- Animal Behavior
Background:
- Psychogenic alopecia in cats is characterized by excessive grooming.
- Behavioral and environmental therapies are common treatments, but their efficacy varies.
Purpose of the Study:
- To evaluate the effectiveness of clomipramine in reducing overgrooming and alopecia in cats.
- To compare clomipramine treatment against untreated cats with psychogenic alopecia.
Main Methods:
- A single pseudo-randomized controlled study was reviewed.
- Outcomes included owner-reported grooming episodes and clinical improvement, alongside veterinary-assessed alopecia and hair regrowth.
Main Results:
- The study found no evidence that clomipramine alone reduced grooming episodes.
- Clomipramine did not significantly improve alopecia or hair regrowth in affected cats.
Conclusions:
- Current evidence suggests clomipramine is not effective for treating psychogenic alopecia in cats when used alone.
- Further high-quality research, including randomized double-blind controlled trials, is necessary to ascertain the efficacy of clomipramine, potentially in combination with other therapies.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Psychosis: Goals of Pharmacotherapy
694
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
694
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K

